Loading...
•
Mar 31, 2022
McKesson Q4 2022 Earnings Report
McKesson's Q4 2022 earnings were reported, revealing a revenue increase but a decrease in earnings per share, while adjusted earnings per share saw growth.
Key Takeaways
McKesson reported a 12% increase in fourth-quarter revenues, reaching $66.1 billion. However, earnings per diluted share decreased, while adjusted earnings per diluted share increased by 15%. The company's full-year revenue also increased by 11%.
Total revenues for the fourth quarter increased by 12% to $66.1 billion.
Earnings per diluted share from continuing operations decreased by $1.67 to $2.48.
Adjusted Earnings per Diluted Share increased by 15% to $5.83.
Full-year revenues increased by 11% to $264.0 billion.
McKesson
McKesson
McKesson Revenue by Segment
Revenue by Segment
U.S. Pharmaceutical Revenue
CapyFin.comPrescription Technology Solutions Revenue
CapyFin.comMedical-Surgical Solutions Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
McKesson expects Adjusted Earnings per Diluted Share of $22.90 to $23.60 for fiscal year 2023, reflecting continued operating momentum and a balanced approach to capital deployment.
Positive Outlook
- Continued operating momentum
- Balanced approach to capital deployment
Revenue & Expenses
Visualization of income flow from segment revenue to net income